REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 81 filers reported holding REPROS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $298,000 | -89.3% | 41,643 | -85.1% | 0.01% | -87.5% |
| Q4 2014 | $2,790,000 | -4.7% | 279,879 | -5.3% | 0.09% | -21.4% |
| Q3 2014 | $2,927,000 | +156.5% | 295,621 | +348.1% | 0.11% | +128.6% |
| Q2 2014 | $1,141,000 | -71.2% | 65,978 | -55.4% | 0.05% | -80.9% |
| Q3 2013 | $3,961,000 | +245.6% | 147,783 | +138.0% | 0.26% | +238.2% |
| Q2 2013 | $1,146,000 | – | 62,090 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $8,413,000 | 2.08% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,445,000 | 0.72% |
| RTW INVESTMENTS, LP | 232,830 | $1,730,000 | 0.54% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 185,500 | $1,378,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 509,060 | $3,782,000 | 0.34% |
| Opus Point Partners Management, LLC | 98,000 | $494,000 | 0.27% |
| J. Goldman & Co LP | 350,000 | $2,601,000 | 0.22% |
| CQS Cayman LP | 240,000 | $1,783,000 | 0.15% |
| Baker Brothers Advisors | 1,955,944 | $14,533,000 | 0.13% |
| Perceptive Advisors | 440,000 | $3,270,000 | 0.13% |